Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye

Figure 1

An 86-year-old male with bilateral neovascular age-related macular degeneration (AMD) ((a) and (b)). Nine days following bevacizumab injection OD, there was a reduction in intraretinal and subretinal fluid OU ((c) and (d)).

(a)

(b)

(c)

(d)